Loading...

Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL 94 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References

(PubMed link indicates BioLegend citation)
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  2. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  3. Kim S, et al. 2020. Development. 147:00:00. PubMed
  4. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  5. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  6. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  7. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  8. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  9. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  10. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  11. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  12. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  13. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  14. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  15. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  16. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  17. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  18. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  19. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  20. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  21. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  22. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  23. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  24. Chan L, et al. 2022. Cells. 12: . PubMed
  25. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  26. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  27. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  28. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  29. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  30. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  31. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  32. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  33. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  34. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  35. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  36. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  37. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  38. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  39. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  40. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  41. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  42. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  43. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  44. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  45. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  46. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  47. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  48. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  49. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  50. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  51. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  52. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  53. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  54. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  55. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  56. Peng, Q., Jiang, P., et al. 2025. Gut Microbes. 17(1),2541028. PubMed
  57. Zhang, N., Li, C., et al. 2025. Cell Death Dis. 17(1),115. PubMed
  58. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  59. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  60. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  61. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  62. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  63. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  64. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  65. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  66. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  67. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  68. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  69. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  70. Stewart CA, et al. 2020. bioRxiv. . PubMed
  71. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  72. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  73. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  74. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  75. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  76. Poli V, et al. 2021. iScience. 24:103256. PubMed
  77. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  78. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  79. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  80. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  81. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  82. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  83. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  84. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  85. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  86. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  87. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  88. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  89. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  90. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  91. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  92. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  93. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  94. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  95. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  96. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  97. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  98. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  99. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  100. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  101. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  102. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  103. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  104. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  105. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  106. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  107. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  108. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  109. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  110. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  111. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  112. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  113. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  114. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  115. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  116. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  117. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  118. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  119. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  120. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  121. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  122. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  123. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  124. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  125. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  126. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  127. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  128. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  129. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  130. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  131. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  132. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  133. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  134. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  135. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  136. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  139. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  140. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  141. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  142. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  143. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  144. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  145. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  146. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  147. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  148. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  149. Kim S, et al. 2020. Development. . PubMed
  150. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  151. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  152. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  153. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  154. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  155. Ma K, et al. 2022. iScience. 25:104347. PubMed
  156. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  157. Lau H, et al. 2020. Islets. 41:12. PubMed
  158. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  159. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  160. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  161. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  162. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  163. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  164. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  165. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  166. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  167. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  168. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  169. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  170. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  171. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  172. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  173. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  174. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  175. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  176. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  177. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  178. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  179. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  180. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  181. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  182. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  183. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  184. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  185. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  186. Lee G, et al. 2021. Viruses. 13: . PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  191. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  192. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  193. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  194. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  195. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  196. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  197. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  198. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  199. Wang X, et al. 2022. Elife. 11:. PubMed
  200. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  201. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  202. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  203. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  204. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  205. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  206. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  207. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  208. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  209. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  210. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  211. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08.26.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account